Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a
Abstract
The canonical Wnt/β-catenin signaling pathway in osteoblast-lineage cells inhibits osteoclastogenesis through the expression of osteoprotegerin (Opg), a decoy receptor of receptor activator of Nf-κb (Rank) ligands. Wnt5a, a typical non-canonical Wnt ligand, enhances the expression of Rank in osteoclast precursors, which, in turn, promotes the Rank ligand (Rankl)-induced formation of osteoclasts. In contrast, Wnt16 and Wnt4 have been shown to inhibit the Rankl-induced formation of osteoclasts through non-canonical Wnt signals. However, the relationships among these Wnt ligands in osteoclastogenesis remained to be elucidated. We herein showed that Wnt16, but not Wnt4, inhibited the Rankl-induced osteoclastogenesis in bone marrow-derived macrophage (BMM) cultures. Wnt3a and Wnt4 inhibited the 1α,25-dihydroxy vitamin D3 (1,25D3)-induced osteoclastogenesis in co-cultures prepared from wild-type mice, but not in those from Opg(-/-) nice. Wnt16 inhibited the 1,25D3-induced formation of osteoclasts in both wild-type and Opg(-/-) co-cultures. Wnt16, Wnt4, and Wnt3a failed to inhibit the pit-forming activity of osteoclasts. Wnt16 failed to inhibit the Wnt5a-induced expression of Rank in osteoclast precursors. In contrast, Wnt5a abrogated the inhibitory effects of Wnt16 on Rankl-induced osteoclastogenesis. These results suggested that Wnt16 inhibited osteoclastogenesis, but not the function of osteoclasts and that Wnt16, an inhibitory Wnt ligand for osteoclastogenesis, regulates bone resorption in conjunction with Wnt5a.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
WNT5a produced by osteoblasts supports osteoclastogenesis by stimulating RANK expression in osteoclast precursors, promoting osteoclast fusion, and supporting actin ring formation and bone resorption via c-Src.
“WNT5a produced by osteoblasts supports osteoclastogenesis by stimulating RANK expression in osteoclast precursors,180 promoting osteoclast fusion,181 and supporting actin ring formation and bone resorption via c-Src.182”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [181]
Cites
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325 · see citing works
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130 · see citing works
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701 · see citing works
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,317 · see citing works
Self-citationWNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093 · see citing works
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2452 · Cited by 1,778 · see citing works
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. (2003) · Nature reviews genetics · doi:10.1038/nrg1122 · Cited by 1,733 · see citing works
Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558 · see citing works
Matrix-embedded cells control osteoclast formation
Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304 · see citing works
Estrada, K., Styrkársdóttir, U., Εvangelou, Ε., Hsu, Y., Duncan, E. L., Ntzani, E., Oei, L., Albagha, O., Amin, N., Kemp, J. P., et al. (2012) · Nature Genetics · doi:10.1038/ng.2249 · Cited by 1,177 · see citing works
van Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L. J. A., de Wilt, E., Karperien, M., Hamersma, H. A., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 893 · see citing works
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., Sato, Y., Nakagawa, N., Yasuda, H., Mochizuki, S.-I., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8697 · Cited by 775 · see citing works
Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3–independent β-catenin degradation
Topol, L. Z., Jiang, X., Choi, H., Garrett-Beal, L. J., Carolan, P. J., & Yang, Y. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303158 · Cited by 724 · see citing works
Maeda, K., Kobayashi, Y., Udagawa, N., Uehara, S., Ishihara, A., Mizoguchi, T., Kikuchi, Y., Takada, I., Kato, S., Kani, S., et al. (2012) · Nature Medicine · doi:10.1038/nm.2653 · Cited by 542 · see citing works
Self-citationIshitani, T., Kishida, S., Hyodo‐Miura, J., Ueno, N., Yasuda, J., Waterman, M. L., Shibuyà, H., Moon, R. T., Ninomiya‐Tsuji, J., & Matsumoto, K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.131-139.2003 · Cited by 540 · see citing works
Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
Movérare‐Skrtic, S., Henning, P., Liu, X., Nagano, K., Saito, H., Börjesson, A., Sjögren, K., Windahl, S. H., Farman, H. H., Kindlund, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3654 · Cited by 364 · see citing works
Aliprantis, A. O., Ueki, Y., Sulyanto, R. M., Park, A., Sigrist, K. S., Sharma, S. M., Ostrowski, M. C., Olsen, B. R., & Glimcher, L. H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35711 · Cited by 346 · see citing works
Wnt5a regulates distinct signalling pathways by binding to Frizzled2
Sato, A., Yamamoto, H., Sakane, H., Koyama, H., & Kikuchi, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.322 · Cited by 317 · see citing works
The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro
Spatz, J., Wein, M. N., Gooi, J. H., Qu, Y., Garr, J., Liu, X. S., Barry, K. J., Uda, Y., Lai, F., Dedic, C., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628313 · Cited by 294 · see citing works
Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-κB
Yu, B., Chang, J., Liu, Y., Li, J., Kevork, K., Al‐Hezaimi, K., Graves, D. T., Park, N.-H., & Wang, C. (2014) · Nature Medicine · doi:10.1038/nm.3586 · Cited by 230 · see citing works
Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis
Okamoto, M., Udagawa, N., Uehara, S., Maeda, K., Yamashita, T., Nakamichi, Y., Kato, H., Saito, N., Minami, Y., Takahashi, N., et al. (2014) · Scientific Reports · doi:10.1038/srep04493 · Cited by 166 · see citing works
Self-citationMedina‐Gómez, C., Kemp, J. P., Estrada, K., Eriksson, J., Liu, J., Reppe, S., Evans, D. M., Heppe, D. H. M., Vandenput, L., Herrera, L., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002718 · Cited by 165 · see citing works
Ikeda, T., Utsuyama, M., & Hirokawa, K. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1416 · Cited by 107 · see citing works
Koller, D. L., Zheng, H., Karasik, D., Yerges‐Armstrong, L. M., Liu, C., McGuigan, F. E., Kemp, J. P., Giroux, S., Lai, D., Edenberg, H. J., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1796 · Cited by 104 · see citing works
Roles for NF-κB and c-Fos in osteoclasts
Boyce, B. F., Yamashita, T., Yao, Z., Zhang, Q., Li, F., & Xing, L. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/bf03026317 · Cited by 101 · see citing works
Self-citationWnt Signaling Regulates Hemopoiesis Through Stromal Cells
Yamane, T., Kunisada, T., Tsukamoto, H., Yamazaki, H., Niwa, H., Takada, S., & Hayashi, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.765 · Cited by 91 · see citing works
Mef2c deletion in osteocytes results in increased bone mass
Krämer, I., Baertschi, S., Halleux, C. M., Keller, H., & Kneissel, M. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1492 · Cited by 85 · see citing works
Koide, M., Kobayashi, Y., Ninomiya, T., Nakamura, M., Yasuda, H., Arai, Y., Okahashi, N., Yoshinari, N., Takahashi, N., & Udagawa, N. (2013) · Endocrinology · doi:10.1210/en.2012-1928 · Cited by 66 · see citing works
Self-citationHendrickx, G., Boudin, E., Fijałkowski, I., et al. (2013) · Bone · doi:10.1016/j.bone.2013.10.022 · Cited by 48 · see citing works
Wei, W., Zeve, D., Wang, X., Du, Y., Tang, W., Dechow, P. C., Graff, J. M., & Wan, Y. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05979-11 · Cited by 46 · see citing works
Nakayama, T., Mizoguchi, T., Uehara, S., et al. (2011) · Bone · doi:10.1016/j.bone.2011.09.045 · Cited by 25 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Bone remodeling: an operational process ensuring survival and bone mechanical competence
Bolamperti, S., Villa, I., & Rubinacci, A. (2022) · Bone Research · doi:10.1038/s41413-022-00219-8 · Cited by 482 · see citing works
Vlashi, R., Zhang, X., Wu, M., & Chen, G. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.07.011 · Cited by 165 · see citing works
Deletion of <i>Wnt5a</i> in osteoclasts results in bone loss through decreased bone formation
Roberts, J. L., Liu, G., Paglia, D. N., Kinter, C. W., Fernandes, L. M., Lorenzo, J., Hansen, M. F., Arif, A., & Drissi, H. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14293 · Cited by 32 · see citing works
- Authors
- Kobayashi, Y., Thirukonda, G. J., Nakamura, Y., Koide, M., Yamashita, T., Uehara, S., Kato, H., Udagawa, N., & Takahashi, N.
- Affiliations
- Matsumoto Dental University (JP)
- Shinshu University (JP)
- Corresponding author
- Kobayashi, Yasuhiro
- ORCID
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 463
- Issue
- 4
- Pages
- 1278-1283
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W577549949
- Cited by
- 47
- References
- 31
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 6 · 2018: 5 · 2017: 3 · 2016: 1 · 2015: 2
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical and Biophysical Research Communications (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science KAKENHI (24390417, 25221310, 25293423)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- WNT16, Wnt5a, osteoclastogenesis, non-canonical Wnt signaling, osteoprotegerin, RANK ligand, RANK expression, bone resorption, 1,25-dihydroxyvitamin D3, bone marrow-derived macrophages, Wnt4, Wnt3a, osteoclast precursors
- MeSH terms
- Wnt-5a Protein, Animals, Calcitriol, Cell Differentiation, Osteoclasts, Mice, Knockout, Coculture Techniques, Wnt Proteins, Mice, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
